Skip to content

Patients with axial spondyloaRthritis: Multi-cOuntry Registry OF clinical characteristics, including radiographic progression, and burden of disease over 5 years in real-life setting

Patients with axial spondyloaRthritis: Multi-cOuntry Registry OF clinical characteristics, including radiographic progression, and burden of disease over 5 years in real-life setting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005630
Enrollment
Unknown
Registered
2014-12-08
Start date
2014-03-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with axial spondyloaRthritis

Interventions

NA:Non-intervention

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients attending a routine visit* at the rheumatologist, who fulfill the following selection criteria, can be included: 1. Current or past CBP for at least 3 months and onset before the age of 45 years; 2. Female or male; 3. older than 18 years of age; 4. Signed a patient authorization form (and informed consent, where applicable) to use and disclose personal health information: * New referrals or existing patients at the rheumatologist are considered ** At the time of enrollment patients do not need to present with CBP; they must have had this condition in the past at least once for a continuous (almost every day) duration of longer than 3 months and before their age of 45 years. CBP does not need to be the symptom for which the patient was referred to the rheumatologist.

Exclusion criteria

Exclusion criteria: Prior diagnosis explaining CBP*** *** amongst other, it refers also to axial SpA (AS or nr-axSpA) diagnosis if made longer than 12 months prior to research Visit 1

Design outcomes

Primary

MeasureTime frame
1.Proportion of patients with CBP longer than 3 months, onset younger than 45 years, evaluated by ASAS classification criteria for axSpA and proportion of patients among these who fulfill the ASAS criteria;;2. Differences in the following scores between patients with nr-axSpA and AS at Visit 1 and 12, 24, 36, 48 and 60 months thereafter:;

Countries

China

Contacts

Public ContactLingyan Zhang
lingyan.y.zhang@abbvie.com+86 10 57061717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026